A Randomized Controlled Trial of a Benefit-finding Intervention for Alzheimer Caregivers

来源 :2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大 | 被引量 : 0次 | 上传用户:taibei
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  To describe the key elements of a benefit-finding (i.e., constructing positive gains) intervention for Alzheimer caregivers using cognitive methods and to report data on the short-term effectiveness of a randomized controlled trial testing the effects of the intervention in reducing caregiver depression and burden.
其他文献
Genes are a major influence on Cognitive impairment and Longevity.In order for a person to live long it is preferable to have inherited genes that do not have a high risk for predisposition to debilit
会议
Dementia is a risk factor to develop care dependency and related nursing care problems (e.g.falls, malnutrition), which often lead to nursing home admission.Internationally, more than 50% of nursing h
会议
The convergence of several unique features of Alzheimers disease (AD) indicates the need for very large cohorts of well-characterized populations from diverse genetic/cultural backgrounds as potential
会议
Antihistamine agent Dimebon belongs to a fast-growing group of "old" drugs that were suggested to be effective for therapy of pathological conditions different from their original targets.The ability
会议
Huntingtons disease is a lethal dominantly inherited disorder characterised by an abnormal CAG repeat expansion of the IT 15 gene and its product mutant Huntingtin protein.The clinical disease usually
会议
Parkinsons disease (PD) is the second most common and progressive neurodegenerative disease affecting about 1% of the aged people.The diagnosis is based on the presence of a set of cardinal motor sign
会议
The CSF biomarkers reflect the molecular changes in the brain.Here, I will focus on CSF soluble amyloid precursor protein β (sAPPβ)and tau in AD, and CSF Aβ 42 in dementia with Lewy bodies (DLB).
会议
Comprehensive studies for identifying normal subjects and individuals with MCI due to AD or early-stage AD by medical imaging and plasma biomarker assays are explored.Subjects of 62 normal controls, 2
会议
The cerebrospinal fluid (CSF) Aβ 42, tau (T-tau) and phosphorylated-tau (at serine 181;P-tau) profile is established as a valuable biomarker for Alzheimers disease (AD), useful for supporting a clinic
会议
In 2014, the Bethanie Group, the largest not for profit Western Australian provider of residential,retirement living and community aged care services, introduced the role of a dementia consultant.
会议